NewswireToday - /newswire/ -
Austin, TX, United States, 2009/06/08 - Sponsor of the 21st Century Nanotechnology Research and Development Act in 2002, Governor George Allen of Virginia is expanding his commitment to safe nanotech implementation as he joins the board of nanoTox’s parent, Nano Risk Assessment, Inc.
nanoTox, the first company to provide complete risk assessment exclusively for nanoparticles, announced today that Governor George Allen of Virginia has joined the board of its parent company, Nano Risk Assessment, Inc. An early supporter of nanotechnology initiatives, Gov. Allen served the Commonwealth of Virginia for more than 20 years as Governor, as U.S. Senator and U.S. Representative, and as a delegate holding Thomas Jefferson’s seat in the Virginia General Assembly.
“Having a passion for the enormous benefits to be derived from advancements in nanotechnology, I am thrilled to join the outstanding, visionary nanoTox team of respected leaders in nanotechnology, science and business,” said Gov. Allen. “Nanotechnology will increasingly improve our lives with innovations in life sciences, materials, micro-electronics and energy. It is clear that the focused expertise of nanoTox will benefit enterprises working with nanoparticles by assessing risk and recommending safe management of their operations. As they innovate, improve and succeed, I foresee many responsible nanobusiness leaders desiring the services of nanoTox.”
Elected to the United States Senate in 2000, George Allen has long advocated policies to make America a leader in innovation and technology. In 2001, he was appointed Chairman of the Senate High Tech Task Force and later in his term he created the Competitive Caucus to keep America the “world capital of innovation”. Allen was a member on the Commerce, Science and Transportation Committee, Small Business and Entrepreneurship Committee, the Energy and Natural Resources Committee as well as Chairman of the Senate Foreign Relations Committee’s Subcommittee on European Affairs.
In 2002, Senator Allen sponsored the 21st Century Nanotechnology Research and Development Act, implementing a National Nanotechnology Program to establish the goals, priorities, and metrics for evaluation of federal nanotechnology research and development, invest in federal nanotech research and development programs, and provide for interagency coordination of federal nanotechnology activities. Senator Allen also joined with Senator Ron Wyden (D-Oregon) to found and Co-Chair the Nanotech Caucus.
In addition to Gov. Allen, the prestigious leaders joining the nanoTox Board of Directors includes former Rice University president Dr. Malcolm Gillis and founder and CEO of private equity firm La Jolla Capital Partners C. Richard Piazza.
“Gov. Allen is one of the foremost supporters of safe nanotechnology development,” said Harry Bushong, nanoTox president. “Not only did he recognize the importance developing strategies to ensure the responsible growth of this technology platform, he helped make it a national priority before most even knew what nanotechnology was.”
“In gaining the guidance and experience of Gov. Allen, Dr. Gillis and Mr. Piazza, nanoTox is well positioned to provide the nanotechnology community with the most valuable expertise available for the safest development of nanomaterials for the commercial market.”
Located in Austin, Texas, nanoTox (nanotox.com) is the first company to provide complete assessment – and solutions – exclusively for nanoparticles. nanoTox determines the toxicity of its clients’ nanoproducts and offers strategies for managing, reducing or eliminating risk to meet state and federal safety guidelines and shorten time to market. Because nanoTox uses methodologies that are performed under recognized international data quality standards (GLP, ISO, etc.) in its laboratories, the results and associated assessments are suitable for use to support regulatory decisions, product registrations, litigation and for acceptance by the insurance industry.
nanoTox ensures complete client confidentiality for all of its clients, which include companies or entities that require government approval to market their nanoproducts, venture capital firms that invest in nanoproduct companies, law firms engaged by such companies and insurance companies considering insuring such companies from liability.